Yup, seriously great news for any company doing the mAB thing. Even if the Prez gets better from the REGN cocktail and doesn't need leronlimab, it's still a positive for CYDY as it will lend immediate credibility to the effectiveness of this class of therapeutics.

Media attention incoming, IMO. Nader needs to dust off his spiffiest suit; Sanjay will be calling any minute now!

P.S. Sanjay Gupta is a former CYDY shareholder.